Kusajili – Clinical trials directory

Result of your search per sponsor: Pierre Fabre Ibérica S.A. as legal representative of Pierr Fabre Mèdicament

Woman Max 99 years
Pierre Fabre Ibérica S.A. as legal representative of Pierr Fabre Mèdicament Update Il y a 4 ans

Phase II trial of oral vinorelbine in combination with capecitabine as first line therapy in women with previously untreated HER2 negative metastatic breast cancer To evaluate the Overall Response Rate (ORR) of oral vinorelbine (Navelbine Oral) in combination with capecitabine (Xeloda) for HER2 negative patients.

Country None
organs None
Specialty None

unknown

More information